Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis

scientific article

Matrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2353/AJPATH.2008.080512
P932PMC publication ID2626385
P698PubMed publication ID18988801
P5875ResearchGate publication ID23456013

P2093author name stringConstance E Brinckerhoff
Jessica S Blackburn
P2860cites workAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activationQ28131755
Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healingQ28131793
PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanismQ28264379
Matrix metalloproteinases and the regulation of tissue remodellingQ29618747
Matrix metalloproteinases: a reviewQ29620220
Matrix metalloproteinase-1 and -9 activation by plasmin regulates a novel endothelial cell-mediated mechanism of collagen gel contraction and capillary tube regression in three-dimensional collagen matrices.Q31954451
RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesisQ40050593
CXCL10 promotes invasion-related properties in human colorectal carcinoma cellsQ40149235
PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.Q40459317
Overexpression of collagenase 1 (MMP-1) is mediated by the ERK pathway in invasive melanoma cells: role of BRAF mutation and fibroblast growth factor signalingQ40548011
Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells.Q40880348
Fragments of human fibroblast collagenase. Purification and characterizationQ41874987
Molecular interpretation of ERK signal duration by immediate early gene productsQ42812329
Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinaseQ43750913
Role of CL-100, a dual specificity phosphatase, in thrombin-induced endothelial cell activationQ45038622
MMP-1 activation by serine proteases and MMP-10 induces human capillary tubular network collapse and regression in 3D collagen matricesQ46471271
Thrombin Induces Proteinase-activated Receptor-1 Gene Expression in Endothelial Cells via Activation of Gi-linked Ras/Mitogen-activated Protein Kinase PathwayQ62944825
Cellular localization of enzymatically active thrombin in intact human tissues by hirudin bindingQ71543614
Fragments of human fibroblast collagenase: interaction with metalloproteinase inhibitors and substratesQ72189792
Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonistQ73045053
Thrombin promotes endothelial cell alignment in Matrigel in vitro and angiogenesis in vivoQ73575612
Complex role of matrix metalloproteinases in angiogenesisQ77474882
Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activationQ80050896
Substrate specificities of matrix metalloproteinase 1 in PAR-1 exodomain proteolysisQ80546519
TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotypeQ33323527
VEGFs, receptors and angiogenesisQ33644265
Proteinase-activated receptors.Q33947141
Effects of thrombin/thrombosis in angiogenesis and tumour progressionQ34017818
Mechanism of thrombin-induced angiogenesisQ34129745
Interstitial collagenases as markers of tumor progressionQ34130340
International Union of Pharmacology. XXVIII. Proteinase-activated receptorsQ34130822
Matrix metalloproteinases in tumor invasion and metastasisQ34136635
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasisQ34249064
Treatment of cancer with anticoagulants: rationale in the treatment of melanomaQ34261285
Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vesselsQ34275284
Role of thrombin in angiogenesis and tumor progressionQ34307545
Angiogenesis assays: a critical overviewQ35036728
Tissue factor, thrombin, and cancerQ35217277
Role of Protease-activated Receptors in the Vascular SystemQ35562739
Protease-activated receptors: contribution to physiology and diseaseQ35715253
Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinomaQ35741707
The chemokine system -- a major regulator of angiogenesis in health and diseaseQ35962626
Metalloproteinases and their inhibitors in tumor angiogenesisQ36053766
Collagenases in cancerQ36076488
Targeting the stromal fibroblasts: a novel approach to melanoma therapyQ36334912
The dynamic roles of angiopoietins in tumor angiogenesisQ36429528
Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis.Q36538338
In vivo models of angiogenesisQ36600421
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotypeQ36650343
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancerQ36753998
In vitro models of angiogenesisQ36764520
Signal transduction and cell-type specific regulation of matrix metalloproteinase gene expression: can MMPs be good for you?Q36892551
Tumor promotion by tumor-associated macrophagesQ36908944
Inhibition of angiogenesis by small-molecule antagonists of protease-activated receptor-1.Q37000497
Tumor stroma and regulation of cancer developmentQ37014752
Matrix metalloproteinase-1 promotes breast cancer angiogenesis and osteolysis in a novel in vivo modelQ37169198
Integrins in angiogenesis and lymphangiogenesisQ37170752
Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells.Q38328320
P4510describes a project that usesImageJQ1659584
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectangiogenesisQ539568
endotheliumQ111140
P304page(s)1736-1746
P577publication date2008-11-06
P1433published inThe American Journal of PathologyQ4744259
P1476titleMatrix metalloproteinase-1 and thrombin differentially activate gene expression in endothelial cells via PAR-1 and promote angiogenesis
P478volume173

Reverse relations

cites work (P2860)
Q83979511A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer
Q37459121A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis
Q34354569BRAF(V600E) melanoma cells secrete factors that activate stromal fibroblasts and enhance tumourigenicity
Q37322052Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis
Q38046798Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?
Q30499994Cathepsin L derived from skeletal muscle cells transfected with bFGF promotes endothelial cell migration
Q35231067Cigarette smoke components induce matrix metalloproteinase-1 in aortic endothelial cells through inhibition of mTOR signaling
Q34770486Coagulation and autoimmunity in scleroderma interstitial lung disease.
Q42379523Complement 3 is involved with ventilator-induced lung injury
Q57026320Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats
Q37394572Differential mechanisms of tumor progression in clones from a single heterogeneous human melanoma.
Q46360418Expression of extracellular matrix metalloproteinase inducer glycosylation and caveolin-1 in healthy and inflamed human gingiva
Q34301563Expression of protease-activated receptor 1 and 2 and anti-tubulogenic activity of protease-activated receptor 1 in human endothelial colony-forming cells
Q38789342Extracellular granzyme K mediates endothelial activation through the cleavage of protease-activated receptor-1.
Q37453552Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1.
Q34457039Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.
Q36542806Matrix metalloproteases and PAR1 activation
Q37439490Matrix metalloproteinase and G protein coupled receptors: co-conspirators in the pathogenesis of autoimmune disease and cancer
Q39486488Matrix metalloproteinase-1 expression enhances tumorigenicity as well as tumor-related angiogenesis and is inversely associated with TIMP-4 expression in a model of glioblastoma
Q36508733Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells
Q36960275Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling
Q38188373Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression.
Q34488791Mouse matrix metalloprotease-1a (Mmp1a) gives new insight into MMP function
Q39093865Neutrophil elastase and proteinase-3 trigger G protein-biased signaling through proteinase-activated receptor-1 (PAR1).
Q52721277Noncanonical Matrix Metalloprotease 1-Protease-Activated Receptor 1 Signaling Drives Progression of Atherosclerosis.
Q41941690PTEN plays an important role in thrombin-mediated lung cancer cell functions
Q33665623Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions
Q87829037Prognostic value of matrix metalloprotease-1/protease-activated receptor-1 axis in patients with prostate cancer
Q37352763Protease induced plasticity: matrix metalloproteinase-1 promotes neurostructural changes through activation of protease activated receptor 1
Q59591342Proteases in Melanoma
Q50129702Proteinases and their receptors in inflammatory arthritis: an overview
Q38966192Proteinases, Their Extracellular Targets, and Inflammatory Signaling.
Q35083186Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy
Q37873891Serine and metalloprotease signaling through PAR1 in arterial thrombosis and vascular injury.
Q33870369Signal transduction by protease-activated receptors
Q84716359Stromal collagenase in melanoma: a vascular connection
Q37862154Tangled fibroblasts in tumor-stroma interactions
Q37308167The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells
Q36405269The MMP-1/PAR-1 Axis Enhances Proliferation and Neuronal Differentiation of Adult Hippocampal Neural Progenitor Cells
Q34503022The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model
Q51723599Therapeutic inhibition of breast cancer bone metastasis progression and lung colonization: breaking the vicious cycle by targeting α5β1 integrin.
Q43963683Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells
Q37451950Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling
Q37903955Tissue factor and cell signalling in cancer progression and thrombosis
Q37125854Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination
Q51720742Upregulation of Thrombin/Matrix Metalloproteinase-1/Protease-Activated Receptor-1 Chain in Proliferative Diabetic Retinopathy.
Q42219763β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.

Search more.